Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
Crossref DOI link: https://doi.org/10.1007/s13555-020-00371-1
Published Online: 2020-04-02
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Scalvenzi, Massimiliano
Cappello, Milena
Costa, Claudia
Fabbrocini, Gabriella
Luciano, Mariaantonietta
Villani, Alessia
Text and Data Mining valid from 2020-04-02
Version of Record valid from 2020-04-02
Article History
Received: 3 March 2020
First Online: 2 April 2020